Sequent Medical's device shows promise in aneurysm study

01/9/2013 |

Using Sequent Medical's intrasaccular flow disrupter for the endovascular treatment of patients with unruptured wide-neck bifurcation aneurysms proved to be feasible in an initial study of 20 patients. The device, called WEB, earned CE mark approval in Europe in 2010 and is being used at selected clinical sites.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR